Study to Investigate the Potential Pharmacological Effect of Oral Palmitoylethanolamide (PEA) Therapy in the Management of Low Back Pain (Neuropathic Pain)

NCT06694337 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Low Back Pain

Interventions

DIETARY_SUPPLEMENT: 300 mg Palmitoylethanolamide (PEA) Phytosome®
DIETARY_SUPPLEMENT: 450 mg Palmitoylethanolamide (PEA) Phytosome®
OTHER: Control group

Sponsor

Liaquat University of Medical & Health Sciences